Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopenia

Prakash Vishnu,1 David M Aboulafia1,2 1Floyd and Delores Jones Cancer Institute at Virginia Mason Medical Center, 2Division of Hematology, University of Washington, Seattle, WA, USA Abstract: Inhibition of platelet production and mediated by antiplatelet antibodies is a well-known mechanism causing...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Vishnu P, Aboulafia DM
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Dove Medical Press 2016-05-01
Cyfres:	Journal of Blood Medicine
Pynciau:	thrombopoietin receptor agonists romiplostim randomized clinical trials immune thrombocytopenia long-term efficacy safety.
Mynediad Ar-lein:	https://www.dovepress.com/long-term-safety-and-efficacy-of-romiplostim-for-treatment-of-immune-t-peer-reviewed-article-JBM
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!